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Abstract
Psychosocial and functional outcomes after intestinal resection in pediatric Crohn’s disease (CD) are lacking. Therefore, we (I)
assessed health-related quality of life (HRQOL), colorectal function, and satisfaction with surgery and (II) investigated their
relationship with surgical outcomes, after ileocecal resection for CD. Crohn’s patients that underwent ileocecal resection during
childhood were included. HRQOL and colorectal function were assessed using SF-36 andCOREFO, respectively, and compared
with reference values. Satisfaction was scored on a 5-point Likert scale. In total, 80 patients (50% male, median age 23.0 years)
were included. Physical HRQOL was impaired (SF-36 [mean]: CD, 47 vs. general, 54; p < 0.001), while mental HRQOL was
similar to that in the general population. Overall colorectal function was impaired (COREFO [mean]: CD, 12.6 vs. normal, 7.2;
p < 0.001). Worse colorectal function was associated with increasing clinical disease activity and longer interval since resection.
Majority of patients was satisfied with surgery (81% satisfied/very satisfied, 11% neither satisfied nor dissatisfied, 8%
dissatisfied/very dissatisfied). Decreased satisfaction with surgery was associated with increased clinical disease activity but
not related to colorectal function.
Conclusions: Physical HRQOL and colorectal function in CD patients who underwent ileocecal resection during childhood
seem impaired and related to adverse surgical outcomes. This emphasizes the need for post-operative monitoring and prophy-
lactic therapies.
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What is Known:
• Up to 25% of pediatric-onset Crohn’s disease (CD) patients undergo an intestinal resection within 5 years from diagnosis.
• Many children and adults with CD experience disruption of their daily activities and health-related quality of life (HRQOL).
What is New:
• Physical HRQOL and colorectal function are impaired in patient with CD that underwent ileocecal resection during childhood.
• Increasing clinical disease activity, a longer interval since surgery, severe complications related to surgery, and recurrent surgeries are all associated
with worse colorectal function.
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anti-TNFα Anti-tumor necrosis factor
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CRP C-reactive protein
HBI Harvey-Bradshaw Index
HRQOL Health-related quality of life
IASC Intra-abdominal septic
complications
IBD Inflammatory bowel disease
PedsQL Pediatric Quality of Life
Inventory 4.0
SF-36 Short form health survey 36
Introduction
Crohn’s disease (CD) is a chronic, recurrent bowel dis-
ease, characterized by patchy, transmural inflammation
which can involve any segment of the gastrointestinal
tract [21]. In 7% to 20% of cases, CD is already diag-
nosed during childhood [5]. Up to 25% of pediatric-onset
CD patients undergo resection within 5 years from diag-
nosis [16]. The majority of these procedures concern
ileocecal resection, especially for disease confined to the
ileocecal region [20].
Irrespective of the surgical treatments, many children
and adolescents with CD experience disruption of their
daily activit ies and health-related quality of life
(HRQOL) [6, 11, 33]. Inducing remission by ileocecal re-
section is associated with significant short-term improve-
ments of HRQOL in adults with CD [12, 28]. However, the
endurance of improved HRQOL following surgery in the
long run is contentious [12, 28]. Post-operative complica-
tions and clinical recurrence are shown to adversely affect
HRQOL in adults with CD post-operatively [28, 31]. Data
on children with CD are limited to a small cohort with
intestinal resections of different extent and location [27].
Besides, it is uncertain whether ileocecal resection impacts
colorectal function. In patients with extensive ileal and
colonic resections, a loss of absorptive capacity for fat, bile
acids, and sodium chloride can lead to diarrhea [2, 14, 19].
Another study including adults with varying resections of
ileum and/or colon observed that resection of the ileocecal
valve and parts of the ascending colon was associated with
more diarrhea compared with resection of the terminal ile-
um alone [25]. Although children with CD tend to undergo
limited resections, indeed the ileocecal valve is resected
too. It is unknown if these patients encounter chronic diar-
rhea likewise.
Therefore, this study aimed to (I) assess HRQOL and co-
lorectal function, (II) investigate the relation between colorec-
tal function and surgical characteristics or adverse outcomes,
and (III) appraise satisfaction with the surgical procedure after
primary ileocecal resection in pediatric CD patients.
Materials and Methods
Patients
In this cross-sectional study, we included all patients with an
established diagnosis of CD according to the (revised) Porto
criteria [23], who underwent primary ileocecal resection for
CD during childhood (age < 18 years) between January 1990
and December 2014 in one of six tertiary hospitals in the
Netherlands (Academic Medical Center, Erasmus Medical
Center, University Medical Center Groningen, University
Medical Center Utrecht, Leiden University Medical Centre,
VU University Medical Center). Primary ileocecal resection
was defined as laparoscopic or open ileocecal resection as first
surgery for CD without a history of other abdominal resec-
tions, except appendectomy. All procedures were performed
by experienced pediatric surgeons. Complications, disease re-
currence, and anthropometrics in this cohort have been pub-
lished previously [9]. The study was approved by the medical
ethics committees and informed consent was given.
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Data collection
Patients were identified from institutional databases covering
all types of surgical procedures. Patients were contacted by
mail and asked to complete questionnaires on clinical disease
activity, HRQOL, colorectal function, and satisfaction with
surgery. If questionnaires were not returned within 6 weeks,
patients were contacted by telephone (maximum of three at-
tempts), by an investigator (K.D.) independent of their
healthcare team. Eligible patients who declined participation
or did not respond to mail and telephone were defined as non-
responders and excluded.
Patient characteristics, surgical details, and disease course
Patient characteristics, surgical details, and disease course af-
ter ileocecal resection were obtained from medical records,
including age, sex, disease phenotype (Paris classification)
[22], CD-related medication, type of approach and anastomo-
sis, primary stoma rate, operating time, and pathology details.
Disease course after ileocecal resection included severe
complications and recurrent abdominal surgery. Severe post-
operative complications were defined as a Clavien-Dindo
classification grade ≥ III (requiring surgical, endoscopic or
radiological intervention) [9, 10]. Recurrent abdominal sur-
gery was defined as disease recurrence requiring new resec-
tion for active inflammation or strictureplasty for
(anastomotic) strictures [9].
Clinical disease activity
Clinical disease activity in patients who reached adulthood (≥
18 years) was determined using the Harvey-Bradshaw Index
(HBI) [17]. The HBI consists of 5 domains, with cut-off scores
for remission (≤ 4), mild (5–7), moderate (8–16), and severe
disease (≥ 17) [17]. Clinical disease activity in pediatric pa-
tients (< 18 years) was determined using the abbreviated
Pediatric Crohn’s Disease Activity Index (aPCDAI) [24, 29].
The aPCDAI consists of six clinical items, with cut-off scores
for remission (≤ 10 points), mild (11–25), moderate (26–39),
and severe disease (≥ 40) [24, 29]. Moderate and severe dis-
eases were analyzed as one group, due to the expected small
group size.
Health-related quality of life
Quality of life was evaluated only in patients who reached
adulthood, as there are no validated tools available that can
reliability assess HRQOL in both adults and children. Adults
completed the Dutch version of the short form health survey 36
(SF-36) [1], a valid instrument for HRQOL assessment in both
healthy and chronically ill adults. Scores were aggregated into
two summary measures: Physical and Mental Component
Summary [34]. Scale scores range from 0 to 100, with higher
scores representing better HRQOL. Mean SF-36 scores from
adult patients were compared with pre-published mean scores
of adults between the age of 26 and 35 years from the Dutch
general population, which were used to validate and norm the
Dutch language version of the SF-36 [1].
Colorectal function
The colorectal function outcome (COREFO) questionnaire is
a validated questionnaire with 27 questions to assess colorec-
tal function [3]. The COREFO questionnaire assesses five
categories: incontinence, social impact, defecation frequency,
stool-related aspects (pain during bowel movements, blood
loss, and local skin problems), and use of medication to thick-
en bowel movements. Scores per category and total score
range from 0 to 100, with higher scores representing worse
outcomes. Mean COREFO scores were compared with the
pre-published mean score of individuals with normal colorec-
tal function, consisting of individuals who had a laparoscopic
cholecystectomy, used in the validation study of the COREFO
questionnaire [3].
Satisfaction with surgery
Satisfaction after primary ileocecal resection was measured
asking the question “how satisfied are you with the performed
surgery (primary ileocecal resection)?.” Answers were given
on a 5-point Likert scale: very satisfied, satisfied, not satisfied
nor dissatisfied, dissatisfied, and very dissatisfied.
Statistical analysis
Patient, disease, and surgical variables between responders
and non-responders were compared. Continuous data were
presented as mean and standard deviation or median and in-
terquartile range (IQR) and unpaired T tests and ANOVAwith
Tukey’s multiple comparison post hoc test.
The Crohnbachα’s of the SF-36 and COREFO scores were
calculated [13]. Crohnbach’s α ≥ 0.60 was considered accept-
able, due to the diversity of items per scale and the small
number of items in some subscales [13]. Cronbach’s α for
all SF-36 items was 0.68. Cronbach’s α for the COREFO total
score was 0.88, with subscores ranking between 0.52 and
0.82, except for the medication subscale (0.39). The
COREFO categories with α’s under the set threshold (i.e.,
medication, stool frequency, incontinence) can be explained
by the few items (two to three) in all of these categories.
HRQOL scores and COREFO total and category scores of
the reference cohort were compared to all CD patients, and
those with disease in clinical remission (HBI ≤ 4 [17],
aPCDAI ≤ 10 [24, 29]) and active disease (HBI > 4 [17],
aPCDAI > 10 [24, 29]) using unpaired T tests or ANOVAwith
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Tukey’s multiple comparison post hoc test, on mean, standard
deviation (SD), and number of subjects.
Associations between colorectal function (COREFO total
and category scores) and clinical disease activity (categorized:
remission, mild, moderate-severe), time since ileocecal resec-
tion, length of resected ileum (excluding the cecum), and oc-
currence of severe complications and recurrent abdominal sur-
gery were identified by univariate linear regression.
Associations between satisfaction with surgery (5-point
Likert scale) and clinical disease activity (categorized: remis-
sion, mild, moderate-severe), time since ileocecal resection, or
age at follow-up were also identified by univariate linear re-
gression. Non-normally distributed continuous variables were
first normalized by natural logarithm. Variables with a two-
sided p value < 0.10 in univariable regressionwere included in
multivariate analysis, additionally corrected for sex and age at
follow-up.
Effect sizes were computed according to Cohen’s d and
categorized as small (0.2–0.5), medium (0.5–0.8), and large
(> 0.8) [4]. Statistical analysis was performed using IBM
SPSS Statistics 22 and GraphPad Prism 5 for Windows. All
statistical tests were two-sided and assessed at a significance
level of 1% for the difference in HRQOL and colorectal func-
tion (to adjust for multiple testing) and at 5% for all other tests.
Results
A total of 114 patients underwent primary ileocecal resection,
of whom 80 patients (50% male, median age at follow-up
23.0 years) were included (response rate 70.1%).
Responders and non-responders did not differ on
sociodemographic variables, disease characteristics, surgical
details, and time of follow-up (variables of responders are
exhibited in Table 1). Indications for ileocecal resection were
stenosis of the ileocecal area (64%), and/or therapy refractory
inflammation (28%), and/or intra-abdominal fistulae or ab-
scesses (26%).
Based on clinical indices, 58 (73%) patients were in remis-
sion, 12 (15%) had mild disease activity, and 10 (13%) had
moderate to severe disease activity at follow-up. At the time of
follow-up, 66 patients reached adulthood, and 14 were still
below the age of 18 years. None of the patients died during
follow-up. The median time of follow-up after primary
ileocecal resection was 81.0 months (IQR 20.5–163.0).
Health-related quality of life
As mentioned in the “Materials and methods” section, quality
of life was assessed in patients that reached adulthood at time
of study (66/80 patients (83%), 56% male, median age at
follow-up 23.5 years (IQR 20.2–31.9), and median follow-
up 102.9 months (IQR 46.5–190.0). Adults with CD who
underwent primary ileocecal resection have a lower physical
health score compared with the general adult population
(mean [SD], 46.9 [10.0] vs. 54.3 [6.5], Cohen’s d 0.88,
p < 0.001). Mental health summary scores did not significant-
ly differ (mean [SD], CD 48.5 [10.5] vs. general 49.9 [9.4],
p = 0.779, Cohen’s d 0.04). When CD patients were sub-
classified based on disease activity, both patients with active
disease (n = 21, p < 0.001) and those in clinical remission (n =
45, p = 0.027) had a lower physical health score compared
with the general population (mean [SD], active 36.8 [6.2] vs.
remission 51.5 [7.8] vs. general, 54.3 [6.5]; Fig. 1). Mental
health scores did only differ between patients with active dis-
ease (p < 0.001) and the general adult population (mean [SD],
active 41.6 [12.6] vs. remission 53.2 [6.8] vs. general, 49.9
[9.4]; Fig. 1).
Colorectal function and associated surgical
characteristics and outcomes
Ileocecal-resected CD patients had significantly higher
COREFO total scores, compared with a normal colorectal func-
tion cohort (total COREFO [mean]: CD, 12.6 vs. normal, 7.2;
p < 0.001). When patients were stratified to clinical remission
(n = 58) or active disease (n = 22), subjects in remission did not
significantly differ from a normal colorectal function cohort on
the COREFO total score, but only on the social impact catego-
ry, with medium effect size (Table 2). Subjects with active
disease did significantly differ from a normal colorectal func-
tion cohort with higher scores for the COREFO total and all
category scores, with medium to large effect sizes (Table 2).
Higher clinical disease activity was associated with higher
COREFO total score (B, 0.27 [95%CI, 0.16–0.39], p < 0.001)
and all category scores (Table 3). A longer duration since
primary ileocecal resection was associated with a higher
COREFO total score (B, 0.40 [95%CI, 0.05–0.75], p =
0.025), and a higher “defecation frequency” (Table 3). A se-
vere complication after ileocecal resectionwas associatedwith
a higher “defecation frequency,” and recurrent abdominal sur-
gery with a “higher need of medication” (Table 3). The length
of the resected ileum was not associated with COREFO total
and category scores (Table 3).
Satisfaction with surgery
Satisfaction with primary ileocecal resection was scored as
follows (high–low): 42 (53%) very satisfied, 23 (29%) satis-
fied, 9 (11%) neither satisfied nor dissatisfied, 4 (5%) dissat-
isfied, and 2 (3%) very dissatisfied. Higher clinical disease
activity was associated with lower satisfaction with surgery
(B, − 0.48 [95%CI, − 0.83 to − 0.12], p = 0.009). The duration
since primary ileocecal resection (B, − 0.27 [95%CI, − 0.98–
0.43], p = 0.439) was not associated with satisfaction with
surgery. Satisfaction with surgery was not related to colorectal
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function (COREFO total score: B, − 0.067 [95%CI, − 0.15–
0.01], p = 0.105).
Discussion
In this multicenter study, we determined HRQOL and colo-
rectal function, investigated the relation between colorectal
function and surgical characteristics and outcomes, and ap-
praised satisfaction with the surgical procedure, in patients
with CD who underwent primary ileocecal resection during
childhood.
Physical HRQOL in adults that underwent ileocecal resec-
tion during childhood was decreased compared with that in
the general population. To date, one study investigated
HRQOL after intestinal resection in children, which reported
decreased HRQOL on physical and social domains in patients
who had missed school or work, but not in those who could
normally attend school or work [27]. Unlike our cohort, this
study included patients with a wide variety of intestinal resec-
tions (ranging from small bowel resections to full
proctocolectomy) and used a visual analog scale to measure
HRQOL, the former introducing heterogeneity and all togeth-
er inhibits adequate comparison. In a study on HRQOL in
adults with CD that underwent ileocecal resection, which
made use of the same HRQOL tool (i.e., SF-36), physical
but not mental HRQOL was impaired, as seen in our cohort
[12]. Lower physical HRQOL also corresponds to previous
studies in general pediatric inflammatory bowel disease (IBD)
populations, which exhibited a decreased physical activity
[35].
In our cohort of ileocecal-resected patients, colorectal func-
tion was impaired compared with that in a cohort with normal
colorectal function. To evaluate if patients with clinically ac-
tive disease would exhibit impaired colorectal function (i.e.,
COREFO scores), we stratified patients into those with clini-
cally active or inactive CD. Indeed, patients with CD in clin-
ical remission had an overall colorectal function similar to a
cohort with normal colorectal function, barring impairment of
social activities due to bowel problems (troublesome urgency
and feeling of incomplete evacuation). Substantial problems
regarding the feeling of incomplete evacuation were also seen
in a small cohort (n = 5) of pediatric CD patients who
underwent an ileal resection [27]. If this can be related to
surgery remains elusive, as feelings of incomplete evacuation
are frequently reported in CD patients not subjected to elective
surgery [8].
Aspects of colorectal function were associated with clinical
disease activity, time since selective surgery, severe complica-
tions related to surgery, and recurrent abdominal surgery after
primary ileocecal resection.
Higher clinical disease activity was associated with de-
creased scores on all enquired colorectal function categories.
It seems plausible and matches the current literature that pa-
tients with active disease after ileocecal resection experience
more problems regarding defecation frequency, stool-related
aspects, and social impact of colorectal function [12, 28, 36].
In particular, increased incontinence problems are trouble-
some. Whether incontinence can be related to ileocecal resec-
tion is unknown. Bile acid malabsorption, attributed to the
reduction in absorptive capacity in patients with extensive
Table 1 Demographic and surgical characteristics of pediatric Crohn’s
disease patients at the time of ileocecal resection
Responders (n = 80)
Male (n, %) 50 (50%)
Age, surgery (median, IQR) 15.0 (14.0–16.0)
Age, follow-up (median, IQR) 23.0 (18.5–30.0)
Age at diagnosisa
A1a, < 10 years (n, %) 7 (9%)
A1b, 10–17 years (n, %) 73 (91%)
Disease location, terminal ileum—colona
L1, distal 1/3 ileum ± limited cecum (n, %) 49 (61%)
L2, colonic (n, %) 0 (0%)
L3, ileocolonic (n, %) 31 (39%)
Disease location, upper gastrointestinala,b (L4a/L4b) 25 (31%)
Disease behaviora
B1, non-stricturing, non-penetrating (n, %) 14 (18%)
B2, stricturing (n, %) 32 (40%)
B3, penetrating (n, %) 9 (11%)
B2B3, stricturing and penetrating (n, %) 25 (31%)
Perianal diseasea (n, %) 18 (23%)
Medical therapy ever used before surgery
Steroids (n, %) 62 (78%)
Anti-TNF-α (n, %) 30 (38%)
Immunomodulators (n, %) 59 (74%)
Mesalazine (n, %) 35 (44%)
Surgical access
Open (n, %) 32 (42%)
Laparoscopy (n, %) 44 (58%)
Anastomosis, type
End-to-end (n, %) 55 (68%)
End-to-side (n, %) 5 (7%)
Side-to-side (n, %) 16 (20%)
Anastomosis, suture technique
Hand-sewn (n, %) 64 (88%)
Stapled (n, %) 9 (12%)
Primary ileostomy (n, %) 2 (2.5%)
Additional procedures (n, %) 9 (11%)
Resection specimen
Length (cm) (median, IQR) 24.0 (18.0–32.0)
Resection margin positivityc (n, %) 44 (55%)
Emergency surgery (n, %) 3 (4%)
Months of follow-up (median, IQR) 81.0 (20.5–163.0)
a According to the Paris classification
b L4a, upper disease proximal to ligament of Treitz; L4b, upper disease distal
to ligament of Treitz and proximal to distal 1/3 ileum
cMicroscopically positive resection margins
anti-TNFα, anti-tumor necrosis factor alpha
Variables containing missing data in included patients (n = 80): preoperative
medication n = 1 (1%); immunomodulators n = 1 (1%);mesalazine n = 1 (1%);
access n = 4 (5%); anastomosis, type n = 4 (5%); anastomosis, suture tech-
nique n = 7 (9%); resection specimen (length) n = 1 (1%); resection specimen
(resection margin positivity) n = 7 (9%), emergency surgery n = 1 (1%)
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ileal resections, has been reported, which may result in diar-
rhea and fecal continence [2, 19]. In our cohort, which primar-
ily included patients with limited ileum resections, no associ-
ations between the length of the resected ileum and inconti-
nence were found.
Interestingly, we observed worse colorectal function with a
longer duration since resection, including increased stool fre-
quency. In a previous cohort of adults who underwent elective
surgery for CD, stool frequency and other symptoms influenc-
ing colorectal function also increased during follow-up [32].
This is likely related to high rates of disease recurrence after
elective surgery, which is a major point of concern. Severe
complications and recurrent abdominal surgery were associat-
ed with higher stool frequency and higher need of medication
or food adjustments (for thickening of bowel movements),
respectively. In a previous study on adult patients who
underwent ileocolonic resections, those with the need of ad-
ditional abdominal surgery experienced impaired intestinal
and systemic functional scores and lower HRQOL [28].
The majority of patients were satisfied or very satisfied
with their ileocecal resection (81%). In agreement with our
cohort, a previous study reports that 80% of patients were
satisfied with surgery and would choose to undergo the pro-
cedure again if necessary [7, 30].
This study has several implications. First, physical
HRQOL after ileocecal resection for pediatric CD was
impaired, indicating the importance of monitoring
HRQOL after surgery. Monitoring of HRQOL can consist
of periodic screening with a suitable questionnaire, as al-
ready performed in our center [18]. Those with psychoso-
cial problems should be referred to psychological health
care on individual or group level [26]. Moreover, the im-
paired HRQOL after surgery should prompt for expecta-
tion management in children undergoing this procedure,
especially because an ileocecal resection usually does not
offer a cure for CD. Secondly, despite quiescent CD, pa-
tients still indicated impairment of social activities due to
colorectal function. This may suggest that despite a lack
Fig. 1 Health-related quality of
life measured with the short form
36 in patients with ileocecal
resection in clinical remission and
with active disease, compared
with subjects in the general
population
Table 2 COREFO total and category scores in patients with CD in remission and active disease compared with a cohort with normal colorectal
function
Normal colorectal
function mean (SD)
Ileocecal resection
Remission mean diff.
(95%CI)
Cohen’s
d
Active disease mean diff.
(95%CI)
Cohen’s
d
Incontinence 5.6 (7.5) − 2.9 (− 0.1–5.8) 0.46 + 4.9 (0.7–9.0)* 0.52
Frequency 6.2 (8.8) + 2.8 (− 1.4–7.1) 0.33 +17.7 (11.8–23.6)* 1.24
Stool-related
aspects
7.7 (12.9) + 2.4 (− 4.4–9.1) 0.16 + 22.2 (12.8–31.7)* 1.05
Need for medication 6.1 (15.6) + 1.7 (− 5.7–9.0) 0.11 + 25.7 (15.4–36.1)* 1.07
Social impact 4.9 (7.9) +5.8 (1.12–10.5)* 0.60 + 35.6 (29.1–42.2)* 2.27
Total score 7.2 (7.0) + 0.5 (− 2.8–3.8) 0.08 + 19.4 (14.8–24.0)* 1.79
COREFO, colorectal function outcome; SD, standard deviation; 95%CI, 95% confidence interval
*Significant difference (p < 0.01)
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of symptoms according to widely used validated clinical
indices, patients with CD still experience debilitating
symptoms after ileocecal resection. This stresses the use
of validated patient-reported outcomes, to reliably mea-
sure how children with CD feel and function after elective
surgery [15]. Thirdly, this study indicates that adverse
surgical outcomes, such as post-operative complications
and recurrent surgery, are associated with impaired colo-
rectal function, which emphasizes the need for careful
post-operative monitoring and prophylactic therapies.
Immediate post-operative therapy after ileocecal resection
reduced the risk of both a symptomatic relapse and a
second resection [9], with anti-TNF-α likely being most
effective [37].
This is the first study that investigated psychosocial and
functional outcomes in patients that underwent a primary
ileocecal resection during childhood, thereby excluding het-
erogeneity due to elective surgeries from various extent and
allows to stratify for the effect of additional resections. The
limitation of this study is the lack of pre- and post-intervention
assessment of HRQOL and colorectal function. Therefore, we
were not able to assess the exact effect of ileocecal resection
on HRQOL, as the cohort was only composed after surgery.
This might raise the question whether ileocecal resection itself
or other disease characteristics, such as disease behavior and
post-operative prophylaxis, are contributing to the decreased
HRQOL and worse colorectal function. Results of the effect
of ileocecal resection on psychosocial and functional out-
comes should be interpreted with caution. Solid conclusions
can therefore not be made. In line with our hypothesis, how-
ever, a study on adults with CD that evaluated pre- and post-
surgery HRQOL showed that ileocecal resection was associ-
ated with significant improvement in the quality of life [36].
Another smaller limitation is the variation in time of follow-up
after surgery, which may lead to potential bias, since risk of
disease recurrence increases with the lapse of time. Therefore,
we corrected for time of follow-up in the multivariable model
on the relation between adverse surgical outcomes and (psy-
chosocial and functional) outcomes after ileocecal resection.
Moreover, the HRQOL (SD-36) and colorectal function ques-
tionnaire (COREFO) cannot perfectly distinguish symptoms
related to the resection form symptomen due to active IBD or
consequences directly related to the resection. Therefore, we
investigated HRQOL and colorectal function in both patients
in clinical remission and in those with active disease.
Physical HRQOL and colorectal function are impaired in
CD patients who underwent ileocecal resection during child-
hood. Despite quiescent CD, patients experience debilitating
social impact due to impaired colorectal function. Higher clin-
ical disease activity and adverse surgical outcomes are asso-
ciated with impair colorectal function. This emphasizes the
need for careful post-operative monitoring and prophylactic
therapies in children with CD.Ta
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